Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial

Lee, JW; Griffin, M; Kim, JS; Lee, LWL; Piatek, C; Nishimura, JI; Infante, CC; Jain, D; Liu, P; Filippov, G; de Fontbrune, FS; Risitano, A; Kulasekararaj, AG

Lee, JW (通讯作者),Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul 06591, South Korea.

LANCET HAEMATOLOGY, 2023; 10 (12): E955

Abstract

Background: Symptoms of anaemia due to clinically significant extravascular haemolysis can affect patients with paroxysmal nocturnal haemoglobinuria (......

Full Text Link